APA (7th ed.) Citation

Ejegod, D. M., Lagheden, C., Bhatia, R., Pedersen, H., Boada, E. A., Sundström, K., . . . Bonde, J. (2020). Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening. BMC cancer, 20(1), 396-13. https://doi.org/10.1186/s12885-020-06888-0

Chicago Style (17th ed.) Citation

Ejegod, Ditte Møller, et al. "Clinical Validation of Full Genotyping CLART® HPV4S Assay on SurePath and ThinPrep Collected Screening Samples According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening." BMC Cancer 20, no. 1 (2020): 396-13. https://doi.org/10.1186/s12885-020-06888-0.

MLA (9th ed.) Citation

Ejegod, Ditte Møller, et al. "Clinical Validation of Full Genotyping CLART® HPV4S Assay on SurePath and ThinPrep Collected Screening Samples According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening." BMC Cancer, vol. 20, no. 1, 2020, pp. 396-13, https://doi.org/10.1186/s12885-020-06888-0.